Cigna Group $CI Shares Sold by Prudent Man Advisors LLC

Prudent Man Advisors LLC lowered its stake in shares of Cigna Group (NYSE:CI) by 1.8% during the second quarter, Holdings Channel reports. The institutional investor owned 2,503 shares of the health services provider’s stock after selling 45 shares during the period. Prudent Man Advisors LLC’s holdings in Cigna Group were worth $827,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in CI. Brighton Jones LLC boosted its holdings in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Cigna Group by 79.0% during the first quarter. GAMMA Investing LLC now owns 5,394 shares of the health services provider’s stock worth $1,775,000 after buying an additional 2,381 shares in the last quarter. Golden State Wealth Management LLC boosted its holdings in Cigna Group by 190.0% during the first quarter. Golden State Wealth Management LLC now owns 812 shares of the health services provider’s stock worth $268,000 after buying an additional 532 shares in the last quarter. Perigon Wealth Management LLC boosted its holdings in Cigna Group by 1.0% during the first quarter. Perigon Wealth Management LLC now owns 8,439 shares of the health services provider’s stock worth $2,777,000 after buying an additional 83 shares in the last quarter. Finally, Pure Financial Advisors LLC boosted its holdings in Cigna Group by 7.3% during the first quarter. Pure Financial Advisors LLC now owns 1,121 shares of the health services provider’s stock worth $369,000 after buying an additional 76 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 1.1%

Shares of NYSE CI opened at $301.84 on Friday. Cigna Group has a 12-month low of $256.89 and a 12-month high of $350.00. The company has a market capitalization of $80.57 billion, a PE ratio of 16.48, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm’s 50-day moving average is $299.22 and its two-hundred day moving average is $307.62.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the prior year, the firm earned $6.72 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s payout ratio is currently 32.97%.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the stock a “buy” rating in a report on Tuesday, August 5th. Guggenheim reissued a “buy” rating and set a $350.00 price objective (down previously from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Wells Fargo & Company boosted their price objective on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a report on Friday. Finally, Wolfe Research reduced their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $369.89.

Insider Buying and Selling

In other news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.